Company profile: TetraScience
1.1 - Company Overview
Company description
- Provider of an R&D cloud data platform for life sciences and drug discovery, offering the Tetra Scientific Data and AI Cloud to manage and analyze scientific data; data replatforming for lab data automation; AI-driven outcomes across the scientific value chain; data engineering with scientific taxonomies and ontologies; GxP-compliant, secure, traceable data management; and analytics and visualization tools.
Products and services
- Tetra Scientific Data and AI Cloud: Architects a cloud-native platform to manage and analyze scientific data for R&D, enabling AI-driven scientific research across life sciences and drug discovery workflows
- Data Engineering: Delivers industrialized scientific taxonomies and ontologies for advanced analytics and AI applications in life sciences R&D
- Data Replatforming: Builds an industrial-grade replatforming system that automates the assembly and contextualization of data in the cloud for lab data automation and management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TetraScience
X-Chem
HQ: United States
Website
- Description: Provider of AI-driven small molecule drug discovery solutions, including ArtemisAI to analyze DEL data and predict new binders; DEL screening services across target classes; medicinal chemistry to convert hits into leads; integrated Dynamic Drug Discovery (XD3); HITMiner to expand binder predictions; and LEADChaser to advance DEL outputs through rapid design-test loops.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Chem company profile →
Pharma Intelligence
HQ: United Kingdom
Website
- Description: Provider of analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharma Intelligence company profile →
ProofPilot
HQ: United States
Website
- Description: Provider of a clinical experience platform designed to streamline recruitment, engagement, and retention for clinical study stakeholders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProofPilot company profile →
Apollo LIMS
HQ: United States
Website
- Description: Provider of laboratory information management systems for hospitals and clinics, based in Nashville, Tennessee, with specialist expertise in clinical, public health, toxicology, and molecular diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apollo LIMS company profile →
Genedata
HQ: Switzerland
Website
- Description: Provider of bioinformatics software and scientific consulting services for drug discovery and life sciences, delivering platforms for biopharma R&D digitalization, screening data analysis, NGS-based cell line development and biosafety, biologics bioprocess design, mass spectrometry–based biotherapeutic characterization and quality monitoring, and multi-omics, biomarker, and clinical data integration for precision medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genedata company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TetraScience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TetraScience
2.2 - Growth funds investing in similar companies to TetraScience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TetraScience
4.2 - Public trading comparable groups for TetraScience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →